| Document |
Document Title |
|
WO/2014/055035A1 |
The invention provides a new and distinct variety of caterpillar medicinal fungus Cordyceps militaris strain CBS 132098 deposited under The Budapest Treaty with the Centralbureau voor Schimmelcultures (CBS) under Accession No. CBS 132098...
|
|
WO/2014/055030A1 |
The invention concerns a food composition product comprises ail essential amino acids, Omega 3 fatty acids and probiotic bacteria, wherein the food composition product allows for a preparation of a mealtime dose comprising at least 15% o...
|
|
WO/2014/053288A1 |
The invention relates to a composition in gel form for preparing a food product, to a process for preparing a food product, and to the use of the composition for preparing a food product. In particular, the invention relates to a gel com...
|
|
WO/2014/055748A1 |
The invention provides methods of increasing immune cell function in a newborn mammal that has not consumed any substantial amounts of colostrum or breast milk comprising administering an infant formula comprising about 1.0 to about 10 g...
|
|
WO/2014/053052A1 |
A pulse protein product having a protein content of at least about 60 wt% (N x 6.25) d.b., preferably a pulse protein isolate having a protein content of at least about 90 wt% (N x 6.25) d.b., is prepared from a pulse protein source mate...
|
|
WO/2014/053944A1 |
This invention provides for a plant extract from the family Moringaceae which suitable for use as an ingredient in a food product, drink, dietary supplement, or a cosmetic product, and a pressurised hot water extraction method for prepar...
|
|
WO/2014/053370A1 |
A foam comprising a drug or mixture of drugs, which foam is composed of a continuous liquid phase and a dispersed gas phase, and which exhibits good in-mouth stability and an overrun of at least 50%, which is dosed in an amount of 50 to ...
|
|
WO/2014/055905A1 |
Disclosed herein are methods for enhancing the efficacy of epigallocatechin gallate ("EGCg") in mitigating skeletal muscle loss in a subject. Providing EGCg to a subject in a nutritional composition reduces muscle protein degradation, th...
|
|
WO/2014/054292A1 |
[Problem] To provide a red colorant obtained from both an iridoid compound and a protein hydrolyzate, the red colorant being capable of stably retaining the color even in acidic liquids and having better light resistance, and a process f...
|
|
WO/2014/053287A1 |
The present invention relates to a shelf-stable liquid or paste concentrate for preparing a food product, to a process for preparing such a concentrate and food product comprising said concentrate. In particular, the invention relates to...
|
|
WO/2014/053561A1 |
A process for preparing a compressed popcorn (15) food product is provided. Process steps include: cooking (1), cooling (2), fractioning (3), heating (4), compressing (5) and ejection and packing (6). Popcorn (15) is made from maize grai...
|
|
WO/2014/053833A1 |
The present invention provides a process for preparing an inhibited starch comprising, in order: a) extracting starch from a native source and partially refining to provide a partially refined starch having a residual protein content on ...
|
|
WO/2014/054421A1 |
The present invention provides a Peyer's patch activator containing polysaccharides obtained from sugar cane as active components. The polysaccharides mainly comprise α-glucans, and have a peak molecular weight in the range of 720,000-1...
|
|
WO/2014/055830A1 |
Disclosed herein are shelf-stable, clear liquid nutritional compositions having a pH ranging from 2.5 to 4.6 and comprising water; at least one source of EGCg in an amount sufficient to provide 200-1700 mg/L of EGCg; and at least one sou...
|
|
WO/2014/049112A1 |
The present patent application relates to liquid concentrated vitamin E (and/or vitamin E derivatives) compositions. The liquid composition comprises vitamin E (and/or vitamin E derivatives) and at least 40 wt-% of at least one polyoxyet...
|
|
WO/2014/050003A1 |
[Problem] To provide a substance capable of safely and effectively modulating expression of a period gene. [Solution] An expression modulator for a period gene containing Pelargonium plant extract as an effective component.
|
|
WO/2014/052056A1 |
An apparatus (10, 10A) and method for increasing Vitamin D content in mushrooms is disclosed. A mushroom slurry of comminuted or pulverized mushrooms or mushroom parts and liquid, such as water, is passed under a UV-B light source (30) a...
|
|
WO/2014/049563A2 |
The invention relates to the oral cosmetic use of a combination of active agents comprising at least taurine, a derivative thereof and/or an acceptable salt thereof and at least one grape extract, as cosmetic active agents for improving ...
|
|
WO/2014/051100A1 |
The objective of the present invention is to provide a therapeutic agent for dermatitis. The present invention is a therapeutic agent for dermatitis, which contains a compound represented by general formula W-X-C(CH3)=CH-CH=CH-C(CH3)=CH-...
|
|
WO/2014/050390A1 |
A composition for food and a fat absorption inhibitor, containing seaweed polyphenol and tea extract.
|
|
WO/2014/052494A1 |
Novel food products and food ingredients include undifferentiated, heterotrophically produced plant cells. The undifferentiated plant cells are produced in cell culture and isolated from the media to form a plant cell food ingredient and...
|
|
WO/2014/051116A1 |
Provided is a lycopene-containing oil-in-water emulsion composition that: comprises an oil phase containing 0.00001-0.1 mass% of lycopene relative to the total mass of the emulsion composition and an aqueous phase containing at least one...
|
|
WO/2014/051428A1 |
The present invention relates to a method of enhancing the nutritional value of food by adding bran to said food, or replacing the bran that already was present in the food by a cereal bran that has been treated with super heated steam (...
|
|
WO/2014/048070A1 |
The present invention provides a composition for promoting erythropoiesis and uses thereof. The composition comprises two or more flavonoid compounds as active ingredients. The flavonoid compound is represented by formula I. R1 is hydrox...
|
|
WO/2014/049023A1 |
The invention relates to products and compositions that may be beneficial in animal husbandry. Said products and compositions comprise microorganisms, such as bacteria, and probiotic bacteria in particular. Thus, provided herein are micr...
|
|
WO/2014/052216A2 |
An edible composition comprising starch and cellulose ether particles, wherein the cellulose ether particles have a ratio M3.0/M2.0 of not more than 200 micrometers, wherein M3.0 is the number volume mean and M2.0 is the number surface a...
|
|
WO/2014/050717A1 |
The present invention effectively ameliorates deterioration in skin condition in terms of sagging, texture, firmness, or the nasolabial folds arising with age. To said end, the present invention uses 1) collagen peptides, 2) proteoglycan...
|
|
WO/2014/050922A1 |
Provided is a technique whereby, in an aqueous liquid composition containing collagen peptides and proteoglycans within a low pH range, the occurrence of clouding or precipitation can be inhibited or a formed precipitate can be easily di...
|
|
WO/2014/048888A1 |
The present invention relates to a composition comprising a compound of the formula I for use as a medicament, wherein R1 is methyl or hydrogen, and wherein R2 is methyl or hydrogen. The invention furthermore relates to food ingredients ...
|
|
WO/2014/049562A2 |
The invention relates to the oral cosmetic use of a combination of active agents comprising at least one polyunsaturated fatty acid and at least one carotenoid, for improving the quality of the nails. More particularly, the present inven...
|
|
WO/2014/048584A1 |
The invention relates to a composition comprising, related to a daily dose of the composition, as its active ingredients L-lysine ranging from ≥ 750 mg to ≤ 9g, suitable as a nutritional supplement or prophylactic and/or therapeutic ...
|
|
WO/2014/049566A2 |
A kit for use in a method of inhibiting damage or demise of myelin-producing cells is disclosed. The method includes administering to a patient in need of such treatment an effective amount of a plurality of nutritional supplements. The ...
|
|
WO/2014/050144A1 |
Provided is a dentinal tubule blocking agent including a calcium-containing component, the calcium-containing component being (i) a phosphorylated saccharide calcium salt, (ii) a combination of a phosphorylated saccharide salt other than...
|
|
WO/2014/050851A1 |
This oral liquid composition is characterized by containing a) poorly water-soluble vitamins, oil components or herbal extracts, b) one or more selected from polyoxyethylene lauryl ether, polyoxyethylene phytosterol, and polyoxyethylene ...
|
|
WO/2014/044990A1 |
The present invention relates to a method for producing an assembly of at least one dairy protein and at least one vegetable protein. The invention also relates to the assembly that can be obtained by said method, as well as to the uses ...
|
|
WO/2014/047614A1 |
Methods and nutritional compositions for improving or enhancing cognitive function, muscle function, or both in a subject are provided. The nutritional compositions comprise a combination of Bacopa and phosphatidylserine-docosahexaenoic ...
|
|
WO/2014/047497A1 |
Disclosed are nutritional compositions, and methods of using and making the nutritional compositions, that include calcium beta-hydroxy-beta-methylbutyrate and protein. The calcium beta-hydroxy-beta-methylbutyrate is in sequestered or io...
|
|
WO/2014/047493A1 |
Disclosed are nutritional compositions, and methods of using and making the nutritional compositions, that include calcium beta-hydroxy-beta-methylbutyrate and protein. The calcium beta-hydroxy-beta-methylbutyrate is in sequestered or io...
|
|
WO/2014/044901A1 |
The invention relates to a snack product and a snack portion with serum LDL cholesterol lowering effect and a pack containing them. The invention is also related to a method for lowering serum LDL cholesterol in a subject in need thereof...
|
|
WO/2014/045177A1 |
The invention relates to a method for extracting and stabilising phycocyanin from at least one material containing same. Said method is characterised in that same includes a step of macerating the material or materials in glycerol or a w...
|
|
WO/2014/046446A1 |
The present invention relates to a method for processing a silkworm having silk protein, a silkworm product processed thereby, and a dietary supplement and a cosmetic composition containing the same. The method for processing a silkworm ...
|
|
WO/2014/045065A2 |
Dietary compositions comprising a carnitine source, a protein source, a carbohydrate source one or more free amino acids, including L-leucine and/or L-phenylalanine, use of said compositions in promoting healthy body composition, includi...
|
|
WO/2014/045561A1 |
The present invention addresses the problems of providing an anticancer drug comprising a carotenoid and of providing a novel carotenoid and an antioxidant comprising the novel carotenoid. The above problems are solved by the discovery t...
|
|
WO/2014/040122A1 |
A nutritional supplement containing fungal biomass having at least 100 mg/kg iron and processes for producing the nutritional supplement using filamentous fungi are described.
|
|
WO/2014/043368A1 |
Disclosed are methods for enhancing learning and/or memory, enhancing memory acquisition, memory retention and recall by inducing a higher long-term potentiation in hippocampal neuronal synapsis in individuals. The methods include admini...
|
|
WO/2014/043330A1 |
Disclosed are methods of modulating and/or decreasing serum corticosterone levels in an individual affected by stress. Further disclosed are methods of modulating the hypothalamic pituitary adrenal response in an individual. The methods ...
|
|
WO/2014/043685A1 |
Disclosed are compositions, such as liquid and solid nutritional compositions, that contain beta-hydroxy-beta-methylbutyric acid and optionally at least one protein, carbohydrate, fat, or a combination of protein, carbohydrate, and fat. ...
|
|
WO/2014/042503A1 |
The invention relates to formula for children of between 0 and 36 months, comprising per 100 g: 5 - 15 g protein, 40 - 70 g carbohydrates, and 15 - 40 g fat. The proteins contain a high concentration of alpha-lactalbumin and A2 beta-case...
|
|
WO/2014/042504A1 |
The invention relates to the production of a nutritional formula intended to be fed to preterm infants. The formula comprises a mixture of casein; whey protein; alpha-lactalbumin; A2 beta-casein protein, lactose; palmitic acid in the bet...
|
|
WO/2014/043064A1 |
A nutritional formulation or dietary regime for improving animal health. The nutritional formulation includes effective and dietary acceptable amounts of glucose tolerance factor (GTF) chromium and L-Glutamine that are beneficial in cont...
|
